Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | RAD51L3 |
| Upstream (Parents) |
|---|
| (<<) ERAP1 → RAD51L3 |
| (<<) GPATCH4 → RAD51L3 |
| Downstream (Children) |
|---|
| RAD51L3 → BRAP (>>) |
| RAD51L3 → CBR1 (>>) |
| RAD51L3 → PLCH1 (>>) |
| RAD51L3 → USH1C (>>) |
| RAD51L3 → NPY6R (>>) |
| RAD51L3 → GABRB1 (>>) |
| RAD51L3 → METTL5 (>>) |
| RAD51L3 → CHD5 (>>) |
| RAD51L3 → ACAP2 (>>) |
| RAD51L3 → EPN2 (>>) |
| RAD51L3 → PARD3 (>>) |
| RAD51L3 → CHRNA3 (>>) |
| RAD51L3 → MYL2 (>>) |
| RAD51L3 → SRGAP3 (>>) |
| RAD51L3 → MSH4 (>>) |
| RAD51L3 → NLE1 (>>) |
| RAD51L3 → TNNC2 (>>) |
| RAD51L3 → STAR (>>) |
| RAD51L3 → TPM2 (>>) |
| RAD51L3 → DNAJC16 (>>) |
| RAD51L3 → PHF15 (>>) |
| RAD51L3 → DYNC1LI2 (>>) |
| RAD51L3 → ZBP1 (>>) |
| RAD51L3 → MYLPF (>>) |
| RAD51L3 → RIC3 (>>) |
| RAD51L3 → FEZ2 (>>) |
| RAD51L3 → SP4 (>>) |
| RAD51L3 → SNTG2 (>>) |
| RAD51L3 → C19orf50 (>>) |
| RAD51L3 → CD5L (>>) |
| RAD51L3 → CYP7B1 (>>) |
| RAD51L3 → CDKN2B (>>) |
| RAD51L3 → ABCB6 (>>) |
| RAD51L3 → CAMKV (>>) |
| RAD51L3 → ZP2 (>>) |
| RAD51L3 → CNN3P1///LOC285780 (>>) |
| RAD51L3 → MYH7///MYH6 (>>) |
| RAD51L3 → TMEM194A (>>) |
| RAD51L3 → PLEKHA4 (>>) |
| RAD51L3 → APCS (>>) |
